Summary
This narrative review synthesises current evidence on silver nanoparticles (AgNPs) as antimicrobial agents, with particular focus on their mechanisms of action against multidrug-resistant (MDR) bacteria. The paper likely covers key challenges including cytotoxicity, environmental persistence, and bacterial resistance development, alongside innovations in nanoparticle synthesis and functionalisation. It appears intended to provide a comprehensive overview of the state of the field for researchers and clinicians working on alternative antimicrobial strategies.
UK applicability
Antimicrobial resistance is a significant public health priority in the UK, and findings on AgNPs as alternative antimicrobial agents are relevant to UK research, healthcare, and regulatory contexts, including MHRA oversight of nanomaterial-based therapeutics. However, as an international review, specific translation to UK clinical practice would require further regulatory and safety evaluation.
Key measures
Antimicrobial mechanisms; minimum inhibitory concentrations; resistance profiles of multidrug-resistant bacteria; nanoparticle synthesis methods and physicochemical properties
Outcomes reported
The review likely examines the antimicrobial mechanisms of silver nanoparticles, their efficacy against multidrug-resistant bacteria, and current challenges and innovations in their development and application.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.